Logo

early detection

Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay

The diagnostics and research services firm will help Mainz recruit research partners for a study assessing new biomarker additions to its CRC early detection test.

Freenome Nets $290M Investment From Roche

The company said the latest influx brings its total funding to more than $1 billion and will help the firm expand its cancer detection platform to multiple tumor types.

Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom
Premium

New companies claimed stakes during the year, established firms solidified their plans and data, and Grail launched the first genomic multi-cancer early detection test.

Burning Rock Details Launch Plans for Three New Oncology Assays in 2022
Premium

The company said it expects to launch an in-licensed lung cancer treatment decision assay next year, alongside its own multi-cancer early detection and MRD products.

BioMark Diagnostics Nabs Canadian Funding for Lung Cancer Liquid Biopsy

The company is developing a metabolomic assay for early detection of lung cancer with academic collaborators at the University of Alberta.

Nov 5, 2021

Pancreatic Cancer Application Provides First Toehold for Biological Dynamics in Clinical Testing
Premium

Oct 28, 2021

Veracyte Builds Data for Lung Cancer Swab Test, Begins Limited Launch
Premium

Sep 30, 2021

Pancreatic Cancer Data Preview Freenome's Plans for Expanded Cancer Detection Assay
Premium

Sep 1, 2021

Burning Rock Details Plans for Cancer Monitoring Assay, Adds New Data Supporting Early Detection
Premium

Aug 27, 2021

Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech
Premium

Aug 18, 2021

Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny

Aug 6, 2021

Guardant Health Laying Path for Future in Cancer Screening, Updates Launch Plans for CRC Assay
Premium

Aug 5, 2021

Guardant Health Q2 Revenues Grow 39 Percent

Aug 5, 2021

Preferred Medicine Building Data for Breast Cancer MicroRNA Screening Test
Premium

Jul 29, 2021

Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project

Jul 20, 2021

Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant

Jul 1, 2021

Canadian Liquid Biopsy Startup Adela to Pursue Cancer Early Detection Tests
Premium

Jun 21, 2021

Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services

Jun 4, 2021

Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data
Premium

May 26, 2021

Burning Rock Embarks on Large-Scale Study for 22-Cancer Screening Assay
Premium

May 25, 2021

Burning Rock Q1 Revenues Rise 58 Percent

May 19, 2021

Caris Life Sciences, Fueled by New Funding, Plans to Expand Liquid Biopsy Testing
Premium

May 13, 2021

Viome Forays Outside Molecularly Informed DTC Wellness Testing With Oral Cancer Assay
Premium

Apr 15, 2021

Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches
Premium

Apr 11, 2021

NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths

Breaking News
The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.